Wealth Architects LLC Reduces Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wealth Architects LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 77.7% during the third quarter, HoldingsChannel reports. The firm owned 464 shares of the medical equipment provider’s stock after selling 1,616 shares during the period. Wealth Architects LLC’s holdings in Intuitive Surgical were worth $228,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in ISRG. Creekmur Asset Management LLC lifted its position in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter worth $26,000. Delos Wealth Advisors LLC raised its holdings in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares during the period. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. Finally, LRI Investments LLC purchased a new stake in shares of Intuitive Surgical in the first quarter valued at about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 0.1 %

Intuitive Surgical stock opened at $515.55 on Thursday. The firm has a market capitalization of $183.63 billion, a P/E ratio of 82.89, a P/E/G ratio of 4.99 and a beta of 1.39. The stock’s fifty day simple moving average is $492.30 and its 200-day simple moving average is $450.05. Intuitive Surgical, Inc. has a twelve month low of $269.49 and a twelve month high of $525.00.

Insider Buying and Selling

In related news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 68,246 shares of company stock worth $33,839,308. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent analyst reports. Raymond James boosted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Barclays upped their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. Mizuho raised their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Finally, Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.